 |
|
_________________________
The winner of our final quiz is Kim G.! Congratulations to all our winners. Each will receive a $50 CVS gift card.
|
|
|
_________________________
Upcoming Events featuring
National CooperativeRx |
|
|
|
Wisconsin County Human Services Association Fall Conference
December 2-3 Hotel Mead, Wisconsin Rapids Learn More
Health Benefits Conference and Expo
January 31 to February 1, 2011
Sheraton Sand Key Resort, Clearwater Beach, FL
|
|
 |
| National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at info@wisrx.com or by phone at 866-679-9479, ext. 223. |
|
|
|
Flu season is here! The Centers for Disease Control and Prevention has free tools and educational resources available to help employers fight the flu at their companies. |
|
New England Journal of Medicine. Four dollar generics have unintended consequences. (Choudhry & Shrank, 11/10) Full story
|
|
Reuters. With bugs in baby formula, glass flakes in intravenous drugs and foul odors emanating from Lipitor and children's Tylenol, a steady stream of high profile product recalls is undermining confidence in top drugmakers. (Berkrot & Richwine, 11/10) Full story
|
|
Consumer Reports Best Buy Drugs. Best Buy Drugs enhances its prescription and over-the-counter drugs effectiveness information through a free, interactive drug look-up tool at AARP.com. Tool
|
|
Wall Street Journal. Doctors identify early signs patients are heading for high blood pressure, but disagree about whether drugs or lifestyle changes are the best treatment. (Landro, 11/9) Full story
|
|
Associated Press. Doctors have sharply cut some financial ties to drug companies, thanks to increased scrutiny about relationships that critics say improperly influence medical treatment, a survey suggests. (Landro, 11/9) Full story
|
|
New York Times. Fosamax and other bone drugs are getting greater scrutiny, and the drugs' popularity and effectiveness for generally healthy women without osteoporosis or broken bones have become a source of increasing argument in doctors' offices and in courtrooms. (Singer 11/10) Full story
|
|
Bloomberg. A new $4,000 per month multiple sclerosis treatment from Novartis could grab 13 percent of that market over the next 12 months. By the time Gilenya has been on the market for two years, it could have a market share of 19 percent, analysts say. (von Schaper, 11/10) Full story
|
|
Related from Bloomberg. Novartis will pay out-of-pocket costs for non-Medicare patients who use the company's new multiple sclerosis pill Gilenya. (Cortez, 10/4) Full story |
|
Kaiser Health News. Kaiser examines implications that could result from disallowing reimbursement for OTC drugs through FSAs. (Andrews, 11/9) Full story
|
|
Politico. The drug industry spent at least $25 million protecting its friends in Congress this year, and was instrumental in several close Democratic Senate contests. And though the group spent more helping embattled Majority Leader Harry Reid than any other member of Congress, its total spending was split about evenly between Democrats and Republicans. (Frates, 11/10) Full story
|
|
Inside Health Reform. The National Association of Chain Drug Stores (NACDS) is asking the IRS to further clarify its new policy affecting the purchase of over-the-counter medications on a tax-free basis and suggesting a two-year delay in implementation may be necessary if the debit card guidance is not changed. (Lotven, 11/10) Full story
|
|
 |
|
